Mirae Asset Global Investments Co., Ltd. Moderna, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 381,422 shares of MRNA stock, worth $44.4 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
381,422
Previous 408,090
6.53%
Holding current value
$44.4 Million
Previous $40.6 Million
0.15%
% of portfolio
0.07%
Previous 0.08%
Shares
18 transactions
Others Institutions Holding MRNA
# of Institutions
1,039Shares Held
245MCall Options Held
12.1MPut Options Held
9.36M-
Baillie Gifford & CO44.7MShares$5.2 Billion3.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA39MShares$4.55 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY25.4MShares$2.96 Billion0.06% of portfolio
-
State Street Corp Boston, MA14.5MShares$1.68 Billion0.07% of portfolio
-
Flagship Pioneering Inc. Cambridge, MA9.67MShares$1.13 Billion67.87% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $45.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...